HHAT and cancer: Accordingly, HHAT knockout leads to a loss-of-function HH phenotype (Chen et al., 2004), and HHAT has been identified as a potential cancer drug target (Konitsiotis et al., 2014; Matevossian and Resh, 2015a; Petrova et al., 2013; Rodgers et al., 2016).